Large gap with delayed quotes
|
Last quote
01/15/2026
-
15:43:21
|
Bid
01/15/2026 -
15:43:39
|
Bid Volume |
Ask
01/15/2026 -
15:44:02
|
Ask Volume |
|---|---|---|---|---|
|
28.60
-0.25
(
-0.87% )
|
28.50
|
98 |
28.65
|
230 |
Analysis date: 13.01.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 09.01.2026.
Interest
Very strong
Very strong
Four stars since 09.01.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 06.01.2026 at a price of 24.45.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 09.01.2026.
4wk Rel Perf
14.47%
14.47%
The four-week dividend-adjusted overperformance versus STOXX600 is 14.47%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.31%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.76%.
Mkt Cap in $bn
1.24
1.24
With a market capitalization <$2bn, POLYPEPTIDE GROUP AG is considered a small-cap stock.
G/PE Ratio
2.87
2.87
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
27.62
27.62
The estimated PE is for the year 2027.
LT Growth
79.26%
79.26%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
172
172
For 1% of index variation, the stock varies on average by 1.72%.
Correlation
0.43
0.43
43.14% of stock movements are explained by index variations.
Value at Risk
11.65
11.65
The value at risk is estimated at CHF 11.65. The risk is therefore 38.89%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
20.08.2021
20.08.2021